Xpovio
Active Ingredient(s): SelinexorFDA Approved: * July 3, 2019
Pharm Company: * KARYOPHARM THERAPEUTICS INC
Category: Cancer
Selinexor sold under the brand name Xpovio among others, is a selective inhibitor of nuclear export used as an anti-cancer medication. It works by blocking the action of exportin 1[2] and thus blocking the transport of several proteins involved in cancer-cell growth from the cell nucleus to the cytoplasm, which ultimately arrests the cell cycle and leads to apoptosis.[3] It is the first drug with this mechanism of action.[4][5] T... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.